Vinicius Antao
Director, Medical Affairs Strategy @Boehringer Ingelheim
Signup · Get unlimited contacts
WORK HISTORY
Director, Medical Affairs Strategy @Boehringer Ingelheim
Ridgefield, CT, US
Medical Affairs strategist driving the launch and lifecycle management of interstitial lung disease assets—particularly Jascayd (nerandomilast)—through evidence generation, cross-functional collaboration, and actionable insight integration across Medical Affairs, MSLs, and Early Asset teams.• Launch Excellence: Co-led multiple advisory boards and continue to shape their strategy and execution, while supporting national and regional congresses to drive scientific exchange, stakeholder engagement, and tactical alignment.• Evidence Generation: Actively involved in multiple RWE and HEOR studies addressing disease burden, treatment disparities, and healthcare utilization in ILDs. Supports registry-based research and manages external research collaborations to close evidence gaps.• Leadership: Serves as Local Out-of-Scope Lead, optimizing the compassionate use process for rare disease therapies.• Innovation & Digital Transformation: Early adopter of AI tools and contributor to the development and implementation of an AI platform for strategic insight management.
EDUCATION
Petropolis Medical School
MD, Internal Medicine
Fluminense Federal University
MSc, Respiratory Medicine
The Johns Hopkins University
Specialization, Health Informatics
Sao Paulo University
PhD, Respiratory Medicine
Gama Filho University
Residency, Occupational Medicine
Rio de Janeiro State University
Residency, Respiratory Medicine
SKILLS
ABOUT VINICIUS ANTAO
With over 25 years of experience across academia, government, and the pharmaceutical industry, I specialize in medical strategy and evidence generation. At Boehringer Ingelheim, I lead Medical Affairs initiatives for interstitial lung disease assets, including the launch of Jascayd (nerandomilast), while advancing RWE and HEOR studies and cross-functional collaboration. Previously, I led Health Outcomes Strategy at the Hospital for Special Surgery, enhancing Patient-Reported Outcome Measures integration and global registry leadership. At the Centers for Disease Control and Prevention, I directed national disease registries and shaped public health policy. My experience includes vaccine strategy and epidemiology at GlaxoSmithKline, with a consistent focus on leveraging data and innovation to improve patient outcomes.Specialties: Medical Affairs, Patient-Reported Outcome Measures, Healthcare Information Technology, Electronic Health Records, Population Health, Registries, Respiratory Medicine, Occupational and Environmental Medicine, Epidemiology.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.